Hartmann, Ann-Kathrin; Bartneck, Joschka; Pielenhofer, Jonas et al.
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejectionFRONTIERS IN IMMUNOLOGY. Bd. 14. 2023
Stickdorn, Judith; Czysch, Christian; Medina-Montano, Carolina et al.
Peptide-Decorated Degradable Polycarbonate Nanogels for Eliciting Antigen-Specific Immune ResponsesINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 24. H. 20. 2023
Heck, Alina G.; Stickdorn, Judith; Rosenberger, Laura J. et al.
Polymerizable 2-Propionic-3-methylmaleic Anhydrides as a Macromolecular Carrier Platform for pH-Responsive Immunodrug DeliveryJOURNAL OF THE AMERICAN CHEMICAL SOCIETY. Bd. 145. H. 50. 2023 S. 27424-27436
Bi, Dongdong; Unthan, Dennis Mark; Hu, Lili et al.
Polysarcosine-based lipid formulations for intracranial delivery of mRNAJOURNAL OF CONTROLLED RELEASE. Bd. 356. 2023 S. 1-13
Wilhelmy, Christoph; Keil, Isabell Sofia; Uebbing, Lukas et al.
Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for ImmunotherapyPHARMACEUTICS. Bd. 15. H. 8. 2023
Zuberbier, Torsten; Peter, Jonny; Staubach, Petra et al.
Potential Therapeutic Approaches for Chronic Urticaria: Beyond H1-Antihistamines and BiologicsJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. Bd. 11. H. 8. 2023 S. 2265-2273
Staubach, Petra; Wurzer, Elisabeth; Hutt, Hans Joachim et al.
Prospective Observational Evaluation of Fixed Combination Calcipotriol/Betamethasone Aerosol Foam (Enstilar (R)) in the Management of Psoriasis with Scalp Involvement in Everyday Clinical Practice (the CAPITIS Study)DERMATOLOGY. 2023
Marques, Richard da Costa; Hueppe, Natkritta; Speth, Kai R. et al.
Proteomics reveals time-dependent protein corona changes in the intracellular pathwayACTA BIOMATERIALIA. Bd. 172. 2023 S. 355-368
Pielenhofer, Jonas; Meiser, Sophie Luise; Gogoll, Karsten et al.
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal ProductPHARMACEUTICS. Bd. 15. H. 2. 2023
Schaller, Theresa; Ringen, Julia; Fischer, Berenice et al.
Reactive oxygen species produced by myeloid cells in psoriasis as a potential biofactor contributing to the development of vascular inflammationBIOFACTORS. 2023